Business Context and Reporting Period
Maiden Holdings, Ltd. (MHLD), a Bermuda-based holding company, filed this Form 8-K on August 13, 2019, to report its financial results for the three and six months ended June 30, 2019. The filing highlights a period of significant strategic restructuring, including the termination of major quota share contracts and the execution of loss portfolio transfers to stabilize the balance sheet.
Key Financial Metrics
Quarter Ended June 30, 2019
- Net Loss: $15.4 million ($0.19 per diluted common share) attributable to common shareholders, compared to a $5.9 million loss in the prior year quarter.
- Non-GAAP Operating Loss: $22.0 million ($0.27 per share).
- Net Premiums Earned: $134.0 million, a significant decrease from $504.4 million in the prior year quarter due to contract terminations.
- Underwriting Loss: $39.1 million, driven by adverse prior year loss development of $26.0 million.
- Combined Ratio: 136.6% (up from 108.1% in 2018).
- Investment Results: Net investment income of $31.1 million and realized gains of $24.1 million.
- Book Value: $1.51 per common share, a 39.8% increase from December 31, 2018.
Six Months Ended June 30, 2019
- Net Loss: $52.0 million ($0.63 per share) attributable to common shareholders, compared to net income of $7.8 million in the prior year period.
- Non-GAAP Operating Loss: $49.0 million ($0.59 per share).
- Net Premiums Earned: $317.1 million, down from $1.02 billion in the prior year.
- Underwriting Loss: $81.9 million.
- Combined Ratio: 132.6% (up from 105.5% in 2018).
- Total Assets: $4.6 billion (down from $5.3 billion at year-end 2018).
- Shareholders' Equity: $590.6 million (up from $554.3 million at year-end 2018).
Material Changes vs. Prior Period
The deterioration in GAAP net income was primarily driven by a $16.7 million non-recurring loss recognized in discontinued operations related to the settlement of the sale of Maiden Reinsurance North America, Inc. (MRNA) to Enstar. Additionally, the company recorded a significant underwriting loss due to the termination of quota share contracts with AmTrust effective January 1, 2019, which drastically reduced premium volume and altered the business mix.
Conversely, the company benefited from $24.1 million in realized investment gains in the quarter, largely from selling corporate bonds to fund strategic transactions. The company also ceased paying dividends on preference shares, saving $8.5 million in the quarter and $17.1 million for the six-month period compared to the prior year.
Guidance, Outlook, and Strategic Transactions
Management stated that the balance sheet continued to stabilize in the second quarter. On August 5, 2019, the company completed several strategic transactions intended to materially strengthen its capital position:
- LPT/ADC with Enstar: A loss portfolio transfer and adverse development cover agreement.
- Commutation with AmTrust: A $330.7 million commutation of certain workers' compensation loss reserves.
- Post-Termination Endorsement: Agreements with AmTrust to support the LPT/ADC and amend loss corridors.
- Resolution with Enstar: Finalized balances due from the MRNA sale, including the cancellation of a $25 million excess of loss contract.
Management expects solvency ratios to continue improving throughout 2019. The primary objective remains restoring a very strong capital position. No dividends were declared on common or preferred shares for the quarter.
Investor Verification Checklist
- Verify the impact of the $16.7 million non-recurring loss in discontinued operations on the GAAP net loss.
- Confirm the details and funding status of the $330.7 million commutation agreement with AmTrust.
- Review the reconciliation of Non-GAAP operating loss to GAAP net loss to understand the exclusion of realized investment gains.
- Assess the sustainability of the 39.8% increase in book value per share given the ongoing underwriting losses.
- Monitor the company's ability to return to operating profitability as it reduces expenses and manages the run-off of terminated business.